With only a few weeks left in the year, concern was rising over why MAPS PBC hadn’t yet submitted its NDA. All that, however, was put to rest yesterday when the Public Benefit Corporation announced that its submission to the FDA was officially complete. On December 12, 2023, the Multidisciplinary Association for Psychedelic Studies Public…
New Merck pneumococcal vaccine wins FDA approval
The Food and Drug Administration on Monday approved Merck’s new pneumococcal vaccine for adults 18 and older. The vaccine, which will be sold under the
June 17, 2024